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Introduction: There is a variety of approaches to pre-procedural imaging of pulmonary veins (PV) and 
left atrium (LA) in order to facilitate atrial fibrillation (AF) ablation, including CT angiography, cardiac 
MRI and intra-procedural three-dimensional rotational angiography (3DRA). Data supporting different 
practices is still evolving and there is an open question whether LA imaging could improve safety and 
outcomes of cryoballoon ablation (CB) ablation.1,2 Here we present the preliminary data from a single-
centre unblinded randomized clinical trial. 
Patients and Methods: So far, we recruited 82 patients (68.3% male, 59.0±11.6 years) with paroxysmal 
(92.8%) and early-persistent AF. Patients were randomized to no imaging or 3DRA which was performed 
intra-procedurally after trans-septal puncture. Angiographic images were segmented and overlaid to 
the fluoroscopy screen to guide the ablation procedure. All patients are followed for 1 year and data 
concerning procedural characteristics, safety outcomes and AF recurrence are being collected. 
Results: Of 82 patients recruited so far, 40 (48%) underwent 3DRA. In patients who received no imaging 
(non-3DRA group) all PVs were successfully isolated while in 3DRA group isolation of one PV could not 
be achieved in 1 patient. Procedure time was significantly longer when 3DRA was performed (89.4±29.7 
min compared to 69.4±21.4 in non-3DRA group, p<0.001). Total radiation dose (146.9±186.1 vs 399.8±216.5 
mGy, p<0.001) and contrast administration (44.2±27.6 vs 136.8±28.4 ml) were significantly lower in the 
control group. Only minor complications were reported in both groups. Three patients developed large 
hematoma (2 in 3DRA group vs 1 in control group). In each group there was one incident of transient 
phrenic nerve palsy. 
Conclusion: 3DRA is a safe and efficient intra-procedural imaging method to guide CB ablation for AF. 
However, it significantly increases procedure duration, total radiation dose and contrast expenditure. 
In our trial it did not have any impact on the acute success rate of PV isolation. One-year follow up data 
is still being collected and will subsequently be presented.
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